AzTrials
AzTrials

StrokeNCT07628374

Effect of Sensorimotor Training Versus Dual-task Training

A study testing Sensorimotor Training, Dual-Task Training and Conventional Physical Therapy in people with Stroke, run by Riphah International University at 1 site in Pakistan.

Recruiting

Looking for participants now. Contact the study team or a site below to ask about taking part.

Sites and contacts
Official record
Search all trials

Trial summary

The aim of this study is to determine the comparative effects of sensorimotor training and dual-task training on propriocetion, balance, functional mobility and fall risk in stroke patients. Read more about this study

Who is it for?
Ages 40 to 60 years
Conditions the study is for
Stroke
What is being tested?
Sensorimotor Training, Dual-Task Training and Conventional Physical Therapy
Could I receive a placebo?
No, everyone receives an active treatment
How many people
54 participants
Where
1 sitePakistan
Study dates
20 Apr 2026to 20 Jul 2026
Phase
Interventional
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 40 to 60 years
  • All sexes
  • No healthy volunteers
  • Adult

Who may be able to join

  • A diagnosis of stroke; ≥6 months after stroke onset
  • Able to walk independently for at least 10 minutes
  • Mini-BESTest score ≤21 indicating balance impairment.
  • MoCA score ≥21 to confirm adequate cognitive function

Who cannot join

  • Severe musculoskeletal conditions (e.g., advanced osteoarthritis, recent fractures) that significantly affect mobility or balance.
  • Significant receptive or expressive aphasia
  • Unstable heart or lung conditions preventing exercise.
  • Active psychiatric disorders (e.g., major depression, schizophrenia)
  • Not community-dwelling before the stroke event
  • Involved in similar rehab or studies within the last 3 months

Trial locations and contacts

1 site in 1 country. Contact the study team or a site near you to ask about taking part.

Pakistan1 site, 1 recruiting
  • DHQ Rajanpur

    Rajanpur, Punjab Province, 33500

    Aisha Naeem

    Recruiting

Other trials in Pakistan

About this study

Official title: Comparative Effects of Sensorimotor Training and Dual-Task Training on Proprioception, Balance, Functional Mobility and Fall Risk in Stroke Patients

The aim of this study is to determine the comparative effects of sensorimotor training and dual-task training on propriocetion, balance, functional mobility and fall risk in stroke patients.

Read the detailed description

Stroke is one of the leading causes of long-term disability worldwide and commonly results in impaired proprioception, balance deficits, reduced functional mobility, gait disturbances, and increased fall risk, particularly in chronic stroke patients. Stroke survivors often experience decreased sensory-motor integration, impaired postural control, reduced coordination, and difficulty performing dual tasks during daily activities, all of which negatively affect independence and quality of life. Sensorimotor training focuses on improving proprioception, neuromuscular control, balance, and postural stability through sensory and motor integration exercises, whereas dual-task training emphasizes simultaneous performance of motor and cognitive tasks to improve cognitive-motor coordination, gait performance, dynamic balance, and functional mobility. The aim of this study is to determine the comparative effects of sensorimotor training and dual-task training on proprioception, balance, functional mobility, and fall risk in chronic stroke patients. This study will be a randomized clinical trial. A non-probability convenience sampling technique will be used to recruit 54 participants diagnosed with chronic stroke. This study will be conducted at Nishtar Hospital, Multan and District Headquarter Hospital, Rajnapur. Participants will be randomly allocated into three groups through sealed opaque envelope method. Group A will receive sensorimotor training, Group B will receive dual-task training, while Group C will receive conventional physical therapy exercises. All groups will perform their respective exercise protocols for 30 minutes, three times a week for 8 weeks. Participants will be evaluated before and after the intervention through Joint Position Sense Test (JPS), Berg Balance Scale (BBS), Mini-BESTest, 6-Minute Walk Test (6MWT), Functional Independence Measure (FIM), and Falls Efficacy Scale-International (FES-I) to assess the effects of interventions on proprioception, balance, functional mobility, and fall risk. Data will be analyzed using SPSS version 26.

Conditions
Stroke
Being tested
Sensorimotor Training, Dual-Task Training, Conventional Physical Therapy
Keywords
Cognitive exercise, Dual-task, Proprioception, Rehabilitation, Sensorimotor exercise, Stroke.
Medical subject headings
Stroke

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Sensorimotor TrainingOther

    Also called Sensroy Retraining/Re-education, Sensory Motor Training

    Somatosensory Training(SMT), for 30 minutes, thrice a week for 8 weeks. Warm-up and cool down will be given.

  • Dual-Task TrainingOther

    Dual-Task Training, for 30 minutes, thrice a week for 8 weeks. Warm-up and cool down will be given.

  • Conventional Physical TherapyOther

    Conventional Physical Therapy, for 30 minutes, thrice a week for 8 weeks. Warm-up and cool down will be given.

Study groups in NCT07628374
Study groupRoleWhat they receive
Sensorimotor TrainingActive comparatorSensorimotor Training
Receives: Other: Sensorimotor Training
Dual-Task TrainingExperimentalDual-Task Training
Receives: Other: Dual-Task Training
Conventional Physical TherapyActive comparatorConventional Physical Therapy
Receives: Other: Conventional Physical Therapy

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Mini-BESTest Scale

    It is a tool to assess dynamic balance across four domains: anticipatory postural adjustments, reactive postural control, sensory orientation, and dynamic gait. It consists of 14 items, each scored from 0 to 2, with a maximum total score of 28. Higher scores indicate better balance performance. The test is sensitive to changes in individuals with neurological conditions, including stroke.

    Measured: 8th week

Secondary outcomes (1)
  1. 6-minute Walk Test(6MWT)

    It is a standardized assessment used to measure functional mobility and endurance by recording the total distance an individual can walk on a flat, hard surface in six minutes. It reflects the ability to perform daily physical activities and is commonly used in patients with neurological and cardiopulmonary conditions, including stroke.

    Measured: 8th week

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted5 Jun 2026
  2. Study start20 Apr 2026
  3. Primary completion5 Jul 2026 (estimated)
  4. Study completion20 Jul 2026 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
Double blind
Who is masked
Participant, Investigator
Enrolment
54 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT07628374
Sponsor's protocol ID
REC/RCR & AHS/25/0215
Status last verified
Jun 2026
First submitted
1 Jun 2026
Last updated
5 Jun 2026
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

A study testing Sensorimotor Training, Dual-Task Training and Conventional Physical Therapy in people with Stroke, run by Riphah International University at 1 site in Pakistan.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 4 inclusion and 6 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: looking for participants now, as of the sponsor's last update on 5 Jun 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Pakistan. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

Contact Imran Amjad (+923324490125, imran.amjad@riphah.edu.pk), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Mini-BESTest Scale (time frame: 8th week). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 5 Jun 2026.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in
Clinical Trial NCT07628374 | AzTrials